☆ 4.1 Letter

Mutational analysis of SOS1 gene in acute myeloid leukemia

INTERNATIONAL JOURNAL OF HEMATOLOGY (2008)

Journal

INTERNATIONAL JOURNAL OF HEMATOLOGY

Volume 88, Issue 4, Pages 460-462

Publisher

SPRINGER TOKYO

DOI: 10.1007/s12185-008-0185-1

Keywords

-

Categories

Hematology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Oncology

Mutational landscape and clinical outcome of pediatric acute myeloid leukemia with 11q23/KMT2A rearrangements

Ka-Yuk Yuen, Yong Liu, Yong-Zhuo Zhou, Yin Wang, Dun-Hua Zhou, Jian-Pei Fang, Lu-Hong Xu

Summary: This study analyzed the mutational landscape of 11q23/KMT2A-rearranged pediatric AML and assessed their prognostic value in outcomes. The results showed that pediatric AML patients with 11q23/KMT2A-rearrangements had a low number of mutations, with most involving RAS pathway mutations. Compared to non-11q23/KMT2A-rearranged AML, 11q23/KMT2A-rearranged AML had significantly higher incidence of KRAS and SETD2 gene mutations. KRAS mutations were associated with worse 5-year event-free survival and overall survival, while SETD2 mutations increased the 5-year relapse rate.

CANCER MEDICINE (2023)

Add to Collection

Article Oncology

Integrative analysis of drug response and clinical outcome in acute myeloid leukemia

Daniel Bottomly, Nicola Long, Anna Reister Schultz, Stephen E. Kurtz, Cristina E. Tognon, Kara Johnson, Melissa Abel, Anupriya Agarwal, Sammantha Avaylon, Erik Benton, Aurora Blucher, Uma Borate, Theodore P. Braun, Jordana Brown, Jade Bryant, Russell Burke, Amy Carlos, Bill H. Chang, Hyun Jun Cho, Stephen Christy, Cody Coblentz, Aaron M. Cohen, Amanda d'Almeida, Rachel Cook, Alexey Danilov, Kim-Hien T. Dao, Michie Degnin, James Dibb, Christopher A. Eide, Isabel English, Stuart Hagler, Heath Harrelson, Rachel Henson, Hibery Ho, Sunil K. Joshi, Brian Junio, Andy Kaempf, Yoko Kosaka, Ted Laderas, Matt Lawhead, Hyunjung Lee, Jessica T. Leonard, Chenwei Lin, Evan F. Lind, Selina Qiuying Liu, Pierrette Lo, Marc M. Loriaux, Samuel Luty, Julia E. Maxson, Tara Macey, Jacqueline Martinez, Jessica Minnier, Andrea Monteblanco, Motomi Mori, Quinlan Morrow, Dylan Nelson, Justin Ramsdill, Angela Rofelty, Alexandra Rogers, Kyle A. Romine, Peter Ryabinin, Jennifer N. Saultz, David A. Sampson, Samantha L. Savage, Robert Schuff, Robert Searles, Rebecca L. Smith, Stephen E. Spurgeon, Tyler Sweeney, Ronan T. Swords, Aashis Thapa, Karina Thiel-Klare, Elie Traer, Jake Wagner, Beth Wilmot, Joelle Wolf, Guanming Wu, Amy Yates, Haijiao Zhang, Christopher R. Cogle, Robert H. Collins, Michael W. Deininger, Christopher S. Hourigan, Craig T. Jordan, Tara L. Lin, Micaela E. Martinez, Rachel R. Pallapati, Daniel A. Pollyea, Anthony D. Pomicter, Justin M. Watts, Scott J. Weir, Brian J. Druker, Shannon K. McWeeney, Jeffrey W. Tyner

Summary: This report presents findings from a large cohort of AML patients, combining genomic, transcriptomic, and clinical data to uncover associations between drug sensitivity, cell differentiation state, and patient survival prediction.

CANCER CELL (2022)

Add to Collection

Review Hematology

FLT3 mutational analysis in acute myeloid leukemia: Advantages and pitfalls with different approaches

Cosimo Cumbo, Francesco Tarantini, Luisa Anelli, Antonella Zagaria, Giorgina Specchia, Pellegrino Musto, Francesco Albano

Summary: This article discusses the analysis of FLT3 gene mutations in AML and debates the strengths and weaknesses of the current gold standard approach. A more comprehensive study of FLT3 mutational status could lead to a reconsideration of its role in AML management.

BLOOD REVIEWS (2022)

Add to Collection

Article Hematology

Genome-wide DNA methylation analysis in pediatric acute myeloid leukemia

Genki Yamato, Tomoko Kawai, Norio Shiba, Junji Ikeda, Yusuke Hara, Kentaro Ohki, Shin-Ichi Tsujimoto, Taeko Kaburagi, Kenichi Yoshida, Yuichi Shiraishi, Satoru Miyano, Nobutaka Kiyokawa, Daisuke Tomizawa, Akira Shimada, Manabu Sotomatsu, Hirokazu Arakawa, Souichi Adachi, Takashi Taga, Keizo Horibe, Seishi Ogawa, Kenichiro Hata, Yasuhide Hayashi

Summary: The study found that DNA methylation patterns were associated with genetic alterations in pediatric patients with acute myeloid leukemia (AML). Specific CpG sites were useful in categorizing patients into different clusters based on methylation levels, which were related to gene expression patterns and prognosis.

BLOOD ADVANCES (2022)

Add to Collection

Article Oncology

Mutational analysis of DNMT3A improves the prognostic stratification of patients with acute myeloid leukemia

Satoshi Wakita, Atsushi Marumo, Kaoru Morita, Shinichi Kako, Takashi Toya, Yuho Najima, Noriko Doki, Junya Kanda, Junya Kuroda, Shinichiro Mori, Atsushi Satake, Kensuke Usuki, Toshimitsu Ueki, Nobuhiko Uoshima, Yutaka Kobayashi, Eri Kawata, Kazutaka Nakayama, Yuhei Nagao, Katsuhiro Shono, Motoharu Shibusawa, Jiro Tadokoro, Masao Hagihara, Hitoji Uchiyama, Naoyuki Uchida, Yasushi Kubota, Shinya Kimura, Hisao Nagoshi, Tatsuo Ichinohe, Saiko Kurosawa, Sayuri Motomura, Akiko Hashimoto, Hideharu Muto, Eriko Sato, Masao Ogata, Kenjiro Mitsuhashi, Jun Ando, Haruko Tashiro, Masahiro Sakaguchi, Shunsuke Yui, Kunihito Arai, Tomoaki Kitano, Miho Miyata, Haruka Arai, Masayuki Kanda, Kako Itabashi, Takahiro Fukuda, Yoshinobu Kanda, Hiroki Yamaguchi

Summary: Nucleophosmin1 (NPM1) mutations are common in acute myeloid leukemia (AML) and have been considered as a favorable prognostic factor. However, our analysis of 605 Japanese AML patients, including 174 with NPM1-mutated AML, showed that NPM1 mutations were not associated with better overall survival (OS). Instead, mutations in the DNMT3A gene (DNMT3A(R882) mutations) were found to be a strong predictor of poor prognosis in all AML cases and NPM1-mutated AML cases. The presence of DNMT3A(R882) mutations, as well as the co-occurrence of FLT3-ITD, NPM1, and DNMT3A(R882) mutations (triple mutations), were independent factors associated with worse OS.

CANCER SCIENCE (2023)

Add to Collection

Article Oncology

Mutant NPM1 Directly Regulates Oncogenic Transcription in Acute Myeloid Leukemia

Hannah J. Uckelmann, Elena L. Haarer, Reina Takeda, Eric M. Wong, Charlie Hatton, Christian Marinaccio, Florian Perner, Masooma Rajput, Noa J. C. Antonissen, Yanhe Wen, Lu Yang, Lorenzo Brunetti, Chun -Wei Chen, Scott A. Armstrong

Summary: The dysregulation of developmental and stem cell-associated genes is a common phenomenon during cancer development. Most patients with acute myeloid leukemia (AML) express high levels of HOXA cluster genes and MEIS1, with an NPM1 mutation (NPM1c) being common in these cases. This study reveals that NPM1c directly binds to specific chromatin targets, collaborates with the MLL1 complex, and directly regulates oncogenic gene expression in AML.

CANCER DISCOVERY (2023)

Add to Collection

Article Immunology

Association Analyses of TP53 Mutation With Prognosis, Tumor Mutational Burden, and Immunological Features in Acute Myeloid Leukemia

Xiang-Mei Wen, Zi-Jun Xu, Ye Jin, Pei-Hui Xia, Ji-Chun Ma, Wei Qian, Jiang Lin, Jun Qian

Summary: AML is a heterogeneous disease with various molecular alterations, and immunotherapy has shown promise in its treatment. TP53 mutation is frequently mutated in AML and is associated with poor prognosis, TMB, and immunological features, making it a potential biomarker for predicting immune response.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Editorial Material Cell & Tissue Engineering

SEPHguarding acute myeloid leukemia

Malini Gupta, Britta Will

Summary: Adaptive aberrant gene regulation is a hallmark of malignant growth and therapy resistance in acute myeloid leukemia (AML). In this study, Eagle et al. identified oncogenic enhancer-driven overexpression of selenophosphate synthetase 2 (SEPHS2) as a targeted opportunity for mitigating malignant cell growth in AML.

CELL STEM CELL (2022)

Add to Collection

Review Oncology

Research progress on molecular biomarkers of acute myeloid leukemia

Pei-Yuan Yin, Rui-Wen Wang, Rui Jing, Xing Li, Jing-Hua Ma, Kai-Min Li, Hua Wang

Summary: Acute myeloid leukemia (AML) is extensively studied at the cellular and molecular levels, with cytogenetic markers being important for diagnosis, prognosis stratification and treatment. However, new technologies have revealed the significance of other molecular markers, such as gene mutations and epigenetic changes, in understanding the disease. Identifying new AML biomarkers contributes to better understanding and individualized treatment.

FRONTIERS IN ONCOLOGY (2023)

Add to Collection

Article Hematology

Analysis of rare driving events in pediatric acute myeloid leukemia

Sanne Noort, Jolieke van Oosterwijk, Jing Ma, Elizabeth A. R. Garfinkle, Stephanie Nance, Michael Walsh, Guangchun Song, Dirk Reinhardt, Martina Pigazzi, Franco Locatelli, Henrik Hasle, Jonas Abrahamsson, Marie Jarosova, Charikleia Kelaidi, Sophia Polychronopoulou, Marry M. van den Heuvel-Eibrink, Maarten Fornerod, Tanja A. Gruber, C. Michel Zwaan

Summary: Detecting genetic aberrations in pediatric acute myeloid leukemia through molecular profiling can provide valuable insights into the biology and clinical outcomes of the disease. This study successfully identified rearrangements and novel mutations in a cohort of pediatric AML patients. The detected aberrations showed distinct gene expression patterns and associations with other diseases such as Ewing sarcoma. The findings highlight the importance of using molecular profiling techniques for diagnostic purposes.

HAEMATOLOGICA (2022)

Add to Collection

Review Biochemistry & Molecular Biology

The Genetic Landscape of Myelodysplastic Neoplasm Progression to Acute Myeloid Leukemia

Claudia Banescu, Florin Tripon, Carmen Muntean

Summary: Myelodysplastic neoplasm (MDS) is a diverse group of myeloid disorders that arise from hematopoietic stem cells and can progress to clonal hematopoiesis. MDS is characterized by an increased risk of transforming into acute myeloid leukemia (AML). Advances in next-generation sequencing (NGS) have revealed numerous recurrent mutations in genes such as FLT3, NPM1, DNMT3A, TP53, NRAS, and RUNX1. The acquisition order of gene mutations during MDS progression to leukemia is non-random and has prognostic significance. Understanding the molecular events behind MDS transformation to AML has paved the way for targeted and personalized treatments.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Add to Collection

Review Biochemistry & Molecular Biology

Role of Biomarkers in the Management of Acute Myeloid Leukemia

Sara Small, Timothy S. Oh, Leonidas C. Platanias

Summary: Despite recent advances in treatment options, predicting responses and long-term prognosis for acute myeloid leukemia (AML) patients remains challenging. Current prognostic assessments mainly focus on genetic and chromosomal abnormalities and response to initial therapy, but fail to explain a large portion of the variability in AML. Laboratory techniques, such as next-generation sequencing and multiparameter flow cytometry, are now being used in clinics to aid in predicting outcomes. Other technological advances, like gene expression analysis, are still being developed for potential clinical use. This review discusses the current utility of biomarkers in AML, as well as novel techniques and strategies being developed. The importance of incorporating measurable residual disease (MRD) and emerging biomarker technologies into clinical practice is emphasized, as they have the potential to improve prognostic power in AML.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Genetics & Heredity

Transcriptome-Wide Analysis of RNA N6-Methyladenosine Modification in Adriamycin-Resistant Acute Myeloid Leukemia Cells

Shu Fang, Bo Peng, Yanan Wen, Jingjing Yang, Hao Wang, Ziwei Wang, Kun Qian, Yan Wei, Yifan Jiao, Chunji Gao, Liping Dou

Summary: This study found that abnormal m(6)A modification plays an important role in Adriamycin-resistant AML. The analysis of sequencing data from HL60 and HL60/ADR cell lines revealed an elevated m(6)A level in the resistant cells, which was associated with multiple signaling pathways.

FRONTIERS IN GENETICS (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Checkpoint Inhibitors in Acute Myeloid Leukemia

Daniela Damiani, Mario Tiribelli

Summary: The prognosis of acute myeloid leukemia (AML) is poor due to tumor cell immune escape, which weakens T-cells. Inhibiting immune checkpoints (ICs) through immune checkpoint inhibitors (ICIs) has emerged as a promising therapeutic strategy for AML. However, the results of clinical trials testing ICIs, alone or in combination with other treatments, in AML are conflicting.

BIOMEDICINES (2023)

Add to Collection

Review Biochemistry & Molecular Biology

Circular RNAs in acute myeloid leukemia

Vijendra Singh, Mohammed Hafiz Uddin, Jeffrey A. Zonder, Asfar S. Azmi, Suresh Kumar Balasubramanian

Summary: While mechanistic studies have shed light on the molecular mechanisms of AML and led to the development of new targeted therapies, resistance remains a significant issue in AML treatment. The exploration of circRNA in AML biology and therapy resistance shows promise in providing new insights and potential solutions to managing this disease.

MOLECULAR CANCER (2021)

Add to Collection

Article Cell Biology

TTBK2 with EB1/3 regulates microtubule dynamics in migrating cells through KIF2A phosphorylation

Takashi Watanabe, Mai Kakeno, Toshinori Matsui, Ikuko Sugiyama, Nariko Arimura, Kenji Matsuzawa, Aya Shirahige, Fumiyoshi Ishidate, Tomoki Nishioka, Shinichiro Taya, Mikio Hoshino, Kozo Kaibuchi

JOURNAL OF CELL BIOLOGY (2015)

Add to Collection

Correction Cell Biology

LRRK1-phosphorylated CLIP-170 regulates EGFR trafficking by recruiting p150Glued to microtubule plus ends (vol 128, pg 385, 2015)

Shin Kedashiro, Strahil Iv. Pastuhov, Tomoki Nishioka, Takashi Watanabe, Kozo Kaibuchi, Kunihiro Matsumoto, Hiroshi Hanafusa

JOURNAL OF CELL SCIENCE (2015)

Add to Collection

Article Biochemistry & Molecular Biology

Increased SPHK2 Transcription of Human Colon Cancer Cells in Serum-Depleted Culture: The Involvement of CREB Transcription Factor

Naoki Mizutani, Yukari Omori, Koji Tanaka, Hiromi Ito, Akira Takagi, Tetsuhito Kojima, Masahiro Nakatochi, Hideo Ogiso, Yoshiyuki Kawamoto, Mitsuhiro Nakamura, Motoshi Suzuki, Mamoru Kyogashima, Keiko Tamiya-Koizumi, Yoshinori Nozawa, Takashi Murate

JOURNAL OF CELLULAR BIOCHEMISTRY (2015)

Add to Collection

Article Neurosciences

Radial Glial Cell-Neuron Interaction Directs Axon Formation at the Opposite Side of the Neuron from the Contact Site

Chundi Xu, Yasuhiro Funahashi, Takashi Watanabe, Tetsuya Takano, Shinichi Nakamuta, Takashi Namba, Kozo Kaibuchi

JOURNAL OF NEUROSCIENCE (2015)

Add to Collection

Letter Hematology

High prophylactic LMWH dose successfully suppressed hemostatic activation in pregnant woman with a new prothrombin c.1787G > Amutation

Mirjana Kovac, Ivo Elezovic, Zeljko Mikovic, Vesna Mandic, Valentina Djordjevic, Dragica Radojkovic, Sanja Lalic-Cosic, Moe Murata, Akira Takagi, Tetsuhito Kojima

THROMBOSIS RESEARCH (2015)

Add to Collection

Article Cell Biology

PAR3-aPKC regulates Tiam1 by modulating suppressive internal interactions

Kenji Matsuzawa, Hiroki Akita, Takashi Watanabe, Mai Kakeno, Toshinori Matsui, Shujie Wang, Kozo Kaibuchi

MOLECULAR BIOLOGY OF THE CELL (2016)

Add to Collection

Article Multidisciplinary Sciences

Tomosyn Negatively Regulates Arginine Vasopressin Secretion in Embryonic Stem Cell-Derived Neurons

Seiji Takeuchi, Shintaro Iwama, Hiroshi Takagi, Atsushi Kiyota, Kohtaro Nakashima, Hisakazu Izumida, Haruki Fujisawa, Naoko Iwata, Hidetaka Suga, Takashi Watanabe, Kozo Kaibuchi, Yutaka Oiso, Hiroshi Arima, Yoshihisa Sugimura

PLOS ONE (2016)

Add to Collection

Article Microscopy

A new approach for the direct visualization of the membrane cytoskeleton in cryo-electron microscopy: a comparative study with freeze-etching electron microscopy

Masaki Makihara, Takashi Watanabe, Eiji Usukura, Kozo Kaibuchi, Akihiro Narita, Nobuo Tanaka, Jiro Usukura

MICROSCOPY (2016)

Add to Collection

Article Microscopy

Perceptually accurate display of two greyscale images as a single colour image

A. B. Taylor, M. S. Ioannou, T. Watanabe, K. Hahn, T. -L Chew

JOURNAL OF MICROSCOPY (2017)

Add to Collection

Article Multidisciplinary Sciences

Discovery of long-range inhibitory signaling to ensure single axon formation

Tetsuya Takano, Mengya Wu, Shinichi Nakamuta, Honda Naoki, Naruki Ishizawa, Takashi Namba, Takashi Watanabe, Chundi Xu, Tomonari Hamaguchi, Yoshimitsu Yura, Mutsuki Amano, Klaus M. Hahn, Kozo Kaibuchi

NATURE COMMUNICATIONS (2017)

Add to Collection

Article Chemistry, Multidisciplinary

Membrane-Permeant, Environment-Sensitive Dyes Generate Biosensors within Living Cells

Christopher J. MacNeyin, Takashi Watanabe, Matthew Weitzman, Akash Gulyani, Sheryl Fuehrer, Nicholas K. Pinkin, Xu Tian, Feng Liu, Jian Jin, Klaus M. Hahn

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2019)

Add to Collection

Article Oncology

miR-221 Targets QKI to Enhance the Tumorigenic Capacity of Human Colorectal Cancer Stem Cells

Junko Mukohyama, Taichi Isobe, Qingjiang Hu, Takanori Hayashi, Takashi Watanabe, Masao Maeda, Hisano Yanagi, Xin Qian, Kimihiro Yamashita, Hironobu Minami, Koshi Mimori, Debashis Sahoo, Yoshihiro Kakeji, Akira Suzuki, Piero Dalerba, Yohei Shimono

CANCER RESEARCH (2019)

Add to Collection

Review Cell Biology

Advances in defining signaling networks for the establishment of neuronal polarity

Yasuhiro Funahashi, Takashi Watanabe, Kozo Kaibuchi

CURRENT OPINION IN CELL BIOLOGY (2020)

Add to Collection

Article Biochemical Research Methods

Spatial models of pattern formation during phagocytosis

John Cody Herron, Shiqiong Hu, Bei Liu, Takashi Watanabe, Klaus M. Hahn, Timothy C. Elston

Summary: This study investigates the mechanisms underlying the formation of phagocytic cups using mathematical modeling and experimental data. The results show that by modifying existing models and adding negative feedback, the experimentally observed rosette pattern of phagocytic cups can be simulated. Two mechanisms are proposed to explain the formation of this pattern, one involving the formation of a ring of high activity by an intermediate signaling molecule, and the other relying on spatial gradients of selectively activated chemical species over the particle.

PLOS COMPUTATIONAL BIOLOGY (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Valosin-containing protein (VCP) is a novel IQ motif-containing GTPase activating protein 1 (IQGAP1)-interacting protein

Norimichi Itoh, Taku Nagai, Takashi Watanabe, Kentaro Taki, Toshitaka Nabeshima, Kozo Kaibuchi, Kiyofumi Yamada

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.